Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Compounds that directly inhibit the androgen receptor discovered at Praecis

Nov. 18, 2002

Novel inhibitors of CDK and GSK-3 identified by Schering researchers

Nov. 15, 2002

Vertex advances Aurora kinase inhibitor into preclinical development

Nov. 14, 2002

Pretreatment of solid tumors with NHS76/PEP2 improves efficacy of chemotherapy in mice

Nov. 14, 2002

Human interferon beta gene therapy with selective activity against RCC

Nov. 13, 2002

Cannabis-based medicine advances to phase II trials in patients undergoing chemotherapy

Nov. 13, 2002

Urokinase inhibitors with utility in cancer covered by Pentapharm patent

Nov. 13, 2002

Taisho claims preparation and use of two series of VEGF antagonists

Nov. 13, 2002

FDA designates Orathecin as a fast track drug

Nov. 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...